High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women

AIDS and Behavior

Volumn 16, Issue 7, 2012, Pages 1775-1786

  Van Der Straten, A ^a,b   Montgomery, E T ^a   Cheng, H ^a   Wegner, L ^a   Masenga, G ^c   Von Mollendorf, C ^d   Bekker, L ^e   Ganesh, S ^f   Young, K ^g   Romano, J ^h   Nel, A ^g   Woodsong, C ^g  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Kiliminjaro Christian Medical Center   (Tanzania)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^g INTERNATIONAL PARTNERSHIP FOR MICROBICIDES   (United States)

^h NWJ Group LLC   (United States)

Author keywords

Acceptability; Africa; HIV STI prevention; Microbicide; Vaginal ring

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CROSSOVER PROCEDURE; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; INTERVIEW; INTRAVAGINAL DRUG ADMINISTRATION; MULTIVARIATE ANALYSIS; NEGRO; PATIENT ATTITUDE; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUALITY; SOCIOECONOMICS; SOUTH AFRICA; STATISTICS; TANZANIA; UTILIZATION REVIEW;

ADMINISTRATION, INTRAVAGINAL; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-INFECTIVE AGENTS; CONTRACEPTIVE DEVICES, FEMALE; CROSS-OVER STUDIES; FEMALE; FOCUS GROUPS; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; QUALITATIVE RESEARCH; QUESTIONNAIRES; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SOCIOECONOMIC FACTORS; SOUTH AFRICA; TANZANIA;

EID: 84868477463     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0215-0     Document Type: Article

References (31)

1. UNAIDS. UNAIDS reports on the global AIDS epidemic 2010. 2010; Available from: http://www.unaids.org/globalreport/default. htm
2. Nel A, Smythe S, Young K, Malcolm K, McCoy C, Rosenberg Z, et al. Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women. J Acquir Immune Defic Syndr. 2009;51(4):416-23
3. Friend DR. Pharmaceutical development of microbicide drug products. Pharm Dev Technol. 2010;15(6):562-81
4. Romano J, Variano B, Coplan P, Van Roey J, Douville K, Rosenberg Z, et al. Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. AIDS Res Hum Retrovir. 2009;25(5):483-8
5. Tolley EE, Harrison PF, Goetghebeur E, Morrow K, Pool R, Taylor D, et al. Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav. 2010;14(5):1124-36
6. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168-74
7. Merkatz RB, Tokay B, Sitruk-Ware RL. Methods for female contraception: a model for innovation in drug delivery systems. Clin Pharmacol Ther. 2009;85(5):553-7
8. Novak A, de la Loge C, Abetz L, van der Meulen EA. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception. 2003;67(3):187-94
9. Shimoni N, Westhoff C. Review of the vaginal contraceptive ring (NuvaRing). J Fam Plan Reprod Health Care. 2008;34(4):247-50
10. Madden T, Blumenthal P. Contraceptive vaginal ring. Clin Obstet Gynecol. 2007;50(4):878-85
11. Sabatinia R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006;74:220-3
12. Nath A, Sitruk-Ware R. Progesterone vaginal ring for contraceptive use during lactation. Contraception. 2010;82(5):428-34
13. Hardy E, Hebling EM, Sousa MH, Almeida AF, Amaral E. Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences. Contraception. 2007;76(2):126-31
14. Stewart FH, Brown BA, Raine TR, Weitz TA, Harper CC. Adolescent and young women's experience with the vaginal ring and oral contraceptive pills. J Pediatr Adolesc Gynecol. 2007;20(6):345-51
15. Smith DJ, Wakasiaka S, Hoang TD, Bwayo JJ, Del Rio C, Priddy FH. An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population. J Womens Health (Larchmt). 2008;17(6):1025-34
16. Woodsong C, Montgomery E, Masenga G, Mollendorf C, Bekker L, Ganesh S, et al., editors. Safety and acceptability of vaginal ring as microbicide delivery method in African women. International partnership for microbicides. Silver Spring, MD; 2010
17. Nel A, Young K, Romano J, Woodsong C, van der Straten A, Masenga G, et al. Safety and acceptability of silicone elastomer vaginal rings as potential microbicide delivery method in African women. International partnership for microbicides. Silver Spring, MD; 2011
18. Simons-Rudolph A, Woodsong C, Koo H. Modeling the social context of microbicide use. Microbicide Q. 2008;6(4):1-11
19. Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev. 2008;20(2):171-87
20. Sahin-Hodoglugil N, Montgomery ET, Kacanek D, Morar NS, Mtetwa S, Nkala B, et al. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in Southern Africa: a theory based qualitative analysis (under review). 2010
21. Woodsong C, Simons-Rudolph A, Alleman P. A comprehensive and flexible conceptual framework for investigating acceptability in microbicide clinical trials (poster presentation). Microbicides 2008. Delhi, India; 2008
22. Montgomery ET, van der Straten A, Cheng H, Wenger L, Mesanga G, Rees H, et al. Vaginal ring adherence in sub-saharan Africa: expulsion, removal, and perfect use. International AIDS conference 2011, July 17-20, Rome, Italy 2011
23. Bhaduri M, Carr LK, Dunn S, Glanc P. The vaginal ring: expelled or misplaced? J Ultrasound Med. 2009;28(2):259-61
24. Kang MS, Buck J, Padian N, Posner SF, Khumalo-Sakutukwa G, van der Straten A. The importance of discreet use of the diaphragm to Zimbabwean women and their partners. AIDS Behav. 2007;11(3):443-51
25. Averbach S, Sahin-Hodoglugil N, Musara P, Chipato T, van der Straten A. Duet®for menstrual protection: a feasibility study in Zimbabwe. Contraception. 2009
26. Mantell J. Women in the time of AIDS: barriers, bargains, and benefits. AIDS Educ Prev. 2008;20(2):91-106
27. Green G, Pool R, Harrison S, Hart GJ, Wilkinson J, Nyanzi S, et al. Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda. Soc Sci Med. 2001;52(4):585-98
28. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Nov 23
29. Nel A, Kamupira M, Woodsong C, Montgomery E, Nuttall J, editors. Safety, acceptability, and adherence of monthly dapiravine vaginal microbicide rings for HIV prevention. 19th conference on retroviruses and opportunistic infections (CROI 2012), 2012 March 5-8, 2012, Seattle, WA
30. Woodsong C, Shedlin M, Koo H. The 'natural' body, God and contraceptive use in the southeastern United States. Culture Health Sex. 2004;6(1):61-78
31. Stadler J, Saethre E. Blockage and flow: intimate experiences of condoms and microbicides in a South African clinical trial. Culture Health Sex. 2011;13(1):31-44